Quality Choice Mucus Relief
- Product NDC
- 63868-998
- 11-digit product format
- 638680998
- Labeler code
- 63868
- Product ID
- 63868-998_e8f6721f-0337-445c-84b2-592329d0ba32
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chain Drug Marketing Association
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2012-08-01
- Substance
- GUAIFENESIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 63868-998-50 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 63868-998-50 | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Quality Choice Mucus Relief
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 400 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 359601 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 41f88b43-3e0a-4650-b167-a72afe6177e8 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63868-998-50 | 2021-05-05 | C162847 | 48780-1 | 9d75b9d0-a86a-f424-e053-dadaa90a57ce | Drug Facts |
| 63868-998-50 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-a86a-f424-e053-dadaa90a57ce | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63868-998-50 | Quality Choice Mucus Relief | 1 in 1 CARTON | TABLET | 1 | 4 | |
| 63868-998-50 | Quality Choice Mucus Relief | 50 in 1 BOTTLE | TABLET | 50 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63868-998-50 | EA - Each | 63868-998 | 5e5affd7-ff26-4bb8-8085-d626098c89e3 | 1 | 2017-04-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Guaifenesin | ACTIVE INGREDIENT | 495W7451VQ | QUALITY CHOICE MUCUS RELIEF (GUAIFENESIN) TABLET [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| Guaifenesin | ACTIVE MOIETY | 495W7451VQ | QUALITY CHOICE MUCUS RELIEF (GUAIFENESIN) TABLET [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| COPOVIDONE | INACTIVE INGREDIENT | D9C330MD8B | QUALITY CHOICE MUCUS RELIEF (GUAIFENESIN) TABLET [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | QUALITY CHOICE MUCUS RELIEF (GUAIFENESIN) TABLET [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| MALTODEXTRIN | INACTIVE INGREDIENT | 7CVR7L4A2D | QUALITY CHOICE MUCUS RELIEF (GUAIFENESIN) TABLET [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | QUALITY CHOICE MUCUS RELIEF (GUAIFENESIN) TABLET [CHAIN DRUG MARKETING ASSOCIATION] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | QUALITY CHOICE MUCUS RELIEF (GUAIFENESIN) TABLET [CHAIN DRUG MARKETING ASSOCIATION] | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vapor Inhaler levmetamfetamine nasal decongestant, TopCare health | LEVMETAMFETAMINE | Topco Associates LLC | 8f995561-759a-4837-a82a-640417a6f889 | 2024-12-20 | Warnings | M012 |
| Childrens Cough | DEXTROMETHORPHAN HBR, GUAIFENESIN | Wal-Mart Stores, Inc. | 50a0eaa5-fa73-4d84-86fc-3546c85cf353 | 2024-12-20 | Warnings | M012 |
| Equate Childrens Multi symptom Cold Nighttime | ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL | Wal-Mart Stores, Inc. | bfdaec98-24fe-47e1-ad32-dc2ddc4ce8ee | 2024-12-20 | Warnings | M012 |
| Vapor Inhaler | LEVMETAMFETAMINE NASAL DECONGESTANT | C.D.M.A., Inc. | 904b7e21-cce5-4b96-afc1-b36f532f98ac | 2024-12-20 | Warnings | M012 |
| Vapor Inhaler levmetamfetamine nasal decongestant, Equaline | LEVMETAMFETAMINE | Supervalu Inc. | 44f72f34-d0b8-421f-b240-86286de874cf | 2024-12-20 | Warnings | M012 |
| Childrens Tussnex | ACTEAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Guardian Drug Company | 19e9678d-ac34-4af8-a80f-d08fce0a5f0e | 2024-12-19 | Warnings | M012 |
| Vaporising Chest Rub | CAMPHOR, MENTHOL, EUCALYPTUS OIL | New Pride Corp | f66476d5-036b-0b1c-e053-2a95a90a0a07 | 2024-12-19 | Warnings | M012 |
| Chest Rub Vaporizing Action | MENTHOL AND CAMPHOR AND EUCALYPTUS OIL | Singhfam Corporation | c6ea663a-9c4f-4d1a-a937-002806a8530a | 2024-12-19 | Warnings | M012 |
| ELIZABETH HEALTH STYLE CHESTRUB VAPORIZING ACTION | CAMPHOR (SYNTHETIC), LEVOMENTHOL, EUCALYPTUS | Singhfam Corporation | f1e4caee-b50e-a0a6-e053-2a95a90aadce | 2024-12-19 | Warnings | M012 |
| Leader Vapor Steam camphor (synthetic) | CAMPHOR (SYNTHETIC) | LEADER/Cardinal Health 110, Inc. | ae580e6c-2efd-c788-e053-2995a90a3360 | 2024-12-19 | Warnings | M012 |
| Tussin DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Strategic Sourcing Service, LLC | 0b6689db-ea34-9a06-e063-6394a90abaf7 | 2024-12-19 | Warnings | M012 |
| Medicated Chest Rub | CAMPHOR, MENTHOL, EUCALYPTUS OIL | Jell Pharmaceuticals Pvt Ltd. | d80b9cc1-55f5-76d5-e053-2995a90aa967 | 2024-12-19 | Warnings | M012 |
| Health Smart Vaporizing Chest Rub | MENTHOL AND CAMPHOR AND EUCALYPTUS OIL | Home Smart Products | acab200e-48bd-69e1-e053-2995a90afde0 | 2024-12-19 | Warnings | M012 |
| Halls MENTHO-LYPTUS | MENTHOL | Mondelez Global LLC | ff21cf0e-9811-4819-bdfc-17a950e9b114 | 2024-12-19 | Warnings | M012 |
| Tussnex FM Cold, Flu and Sore Throat | ACTEAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Guardian Drug Company | 7bddce11-c227-4d95-94c1-6f41ecd7285b | 2024-12-19 | Warnings | M012 |
| Childrens Tussnex Multi-symptom cold | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Guardian Drug Company | 9028676e-d725-4afe-aa14-72235825aa17 | 2024-12-19 | Warnings | M012 |
| Tussnex FM Cold and Sinus | ACTEAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Guardian Drug Company | 04c6bb6a-d2f8-4322-afba-e240e8090176 | 2024-12-19 | Warnings | M012 |
| Tussnex FM Severe cough and congestion | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Guardian Drug Company | 387df403-7803-4031-915e-8de9b103a162 | 2024-12-19 | Warnings | M012 |
| Maximum strength Tussnex FM DM Max | DEXTROMETHORPHAN HBR, GUAIFENESIN | Guardian Drug Company | 0bae53e3-9661-4bc6-9fcc-da7fa131b034 | 2024-12-19 | Warnings | M012 |
| Vicks Vaposteam Lavender | CAMPHOR, (-)- | Kaz USA, Inc | 03bf6b78-cf8e-44c6-bae0-5bd0a85f8aa9 | 2024-12-19 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 359601 | guaiFENesin 400 MG Oral Tablet | PSN | 41f88b43-3e0a-4650-b167-a72afe6177e8 | 4 |
| 359601 | guaifenesin 400 MG Oral Tablet | SCD | 41f88b43-3e0a-4650-b167-a72afe6177e8 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63868-998-50 | 63868099850 | 1 BOTTLE in 1 CARTON (63868-998-50) / 50 TABLET in 1 BOTTLE | 1 bottle | 2012-08-01 | 0000-00-00 | No | No | Current |